Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: liquid paraffin; monobasic sodium phosphate dihydrate; phosphoric acid; white soft paraffin; cetomacrogol 1000; cetostearyl alcohol; sodium hydroxide; chlorocresol; purified water - indications as at 22 november 1995: diprosone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone valerate, quantity: 0.244 mg/g - cream - excipient ingredients: purified water; sodium hydroxide; chlorocresol; cetostearyl alcohol; cetomacrogol 1000; phosphoric acid; white soft paraffin; liquid paraffin; monobasic sodium phosphate dihydrate - indications as at 30 april 1991: for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritus, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, stasis dermatitis and psoriasis. celestone -m is indicated for maintenance therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 0.2 mg/g - cream - excipient ingredients: emulsifying wax; benzyl alcohol; lactic acid; purified water; glycerol; sorbitol solution (70 per cent) (non-crystallising); isopropyl palmitate - indications as at 22 october 1998: in the treatment of the following dermatoses: atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, exzematised psoriasis, neurodermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - estriol, quantity: 1 mg/g - cream - excipient ingredients: sodium hydroxide; stearyl alcohol; lactic acid; cetyl esters wax; purified water; chlorhexidine hydrochloride; sorbitan monostearate; octyldodecanol; glycerol; polysorbate 60; cetyl alcohol - indications as at 18 december 2001. vulvo-vaginal complaints due to oestrogen deficiency associated with the climacteric and the postmenopause or after ovariectomy: atrophic vaginitis. puritis vulvae. dyspareunia due to vulvo-vaginal atrophy. as auxiliary therapy in the treatment of vaginal infections. as pre-operative therapy for vulvo-vaginal surgery and during subsequent convalescence. ulcers in the case of prolapse of the uterus or vagina. to avoid misinterpretation of a cytological smear.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - fluorouracil, quantity: 50 mg/g - cream - excipient ingredients: methyl hydroxybenzoate; propyl hydroxybenzoate; polysorbate 60; white soft paraffin; purified water; propylene glycol; stearyl alcohol - indications as at 30 july 1990: solar and senile keratoses, bowen's disease.

Israel - English - Ministry of Health

bayer israel ltd - clotrimazole - cream - clotrimazole 1 %w/w - clotrimazole - clotrimazole - for the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, moulds and other fungi such as malassezia furfur as well as skin infections caused by corynebacterium minutissimum. indicated also for candida vulvitis and candida balanitis.

Israel - English - Ministry of Health

padagis israel pharmaceuticals ltd, israel - butenafine hydrochloride - cream - butenafine hydrochloride 1 % - butenafine - butenafine - interdigital tinea pedis, tinea coporis, tinea cruris . (treatment in tinea coporis and tinea cruris is limited to up to 4 weeks).

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - clobetasol 17- propionate - cream - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. these include the following:• psoriasis (excluding widespread plaque psoriasis)• recalcitrant dermatoses • lichen planus• discoid lupus erythematosus • other skin conditions which do not respond satisfactorily to less potent steroids.

Israel - English - Ministry of Health

j-c health care ltd - hydrocortisone; miconazole nitrate - cream - hydrocortisone 10 mg/g; miconazole nitrate 20 mg/g - hydrocortisone and antibiotics - hydrocortisone and antibiotics - infections of the skin caused by dermatophytes or candida species in which inflammatory symptoms are prominent.

Israel - English - Ministry of Health

dexcel ltd, israel - betamethasone as valerate; fusidic acid - cream - fusidic acid 2 %; betamethasone as valerate 0.1 % - betamethasone and antibiotics - betamethasone and antibiotics - treatment of eczematous dermatoses when secondary bacterial infection is confirmed.